By Claim Construction Order entered in GlaxoSmithKline, LLC v. Genentech, Inc., C.A. No. 10-799-GMS (D.Del., August 23, 2013), the Honorable Gregroy M. Sleet construed two disputed terms in U.S. Patent No. RE41,555 (the “patent-in-suit”).

A complete copy of the Claim Construction Order is attached.